Life Sciences Panel - April 12
Life Sciences Panel: Disruption & Innovation in the Future of Biotech Facilities
With the largest concentration of life science researchers in the US, employment rates are high and vacancies are low in Greater Boston. With an influx of new start-ups and influence of Big-Bio, life science facilities are continuously changing to meet the needs of the companies that call them home. This panel brings together diverse perspectives to discuss how facilities are accommodating the evolving needs of life science companies from inception to maturity. Some highlights of the talk will include:
- Are there gaps in the real estate market at certain stages of company development and how can facility infrastructure offered by developers be modified to accommodate this.
- Where is science going? It’s evolving; are facilities keeping up with the changes? Are they forward thinking?
- Are facilities responding to new research missions such as personalized medicine? What do/should these facilities look like as opposed to traditional labs?
- Is there anything that is impeding the right development to support evolving science and the appropriate infrastructure
Jeffrey J. Talka, AIA, NCARB, LEED AP | Science & Technology Practice Leader, SLAM Collaborative
Mr. Talka has over 35 years of experience as a practicing architect with over the last 25 years focused on research and development facilities for the bio/medical, cleanroom and pharmaceutical sectors, with over 3 million SF of successfully executed projects. Jeff has programmed, designed, managed, and peer reviewed such facilities on a worldwide basis. His experience ranges from academic research laboratories to vivaria, drug development and research (GLP/GMP), and nanotechnology facilities, and he is sought as a speaker on the design of these facilities from an integrated architecture-engineering approach. He has established a program of book-ending services which attach pre-design and programming to the front-end of project basic services and commissioning, validation, and user-friendly operations support on the back end.
Samir Gondalia Senior Scientist, Pfize
Samir Gondalia is a Senior Scientist at Pfizer, Inc., a global biopharmaceutical company, in Andover, MA. Samir has been an active member of ISPE since 2011 and served as Chair of the Boston Area Chapter Member Services Committee from 2014 to 2016. Samir has over 17 years of biotech industry experience in pilot and clinical manufacturing facilities. Currently he is working as a downstream SME for Pfizer’s expansion in the emerging markets. He holds an M.S. in Chemical Engineering from Stevens Institute of Technology and a B.S. in Chemical Engineering from Gujarat University. Samir enjoys tennis, cooking, and oil painting.
Pat Gallagher| President & CEO, Hereva Consultants
Pat Gallagher is the President and CEO of Hereva Consultants, managing a team that specializes in client representation and project management. He has thirty years of experience in the construction industry as a Cost Consultant, Owners Representative and Project Manager. Pat’s experience in the biopharmaceutical and life-science industry spans the local, national and global real estate market, and he has represented Owners in the planning, design, construction and operational start-up of millions of square feet of newly constructed and renovated laboratory and cGMP drug-substance manufacturing buildings. For nearly twenty years, Pat has been actively involved in the local Boston, Cambridge and eastern Massachusetts biotech industry. He received his Bachelor’s Degree, with honors, in the Cost Management of Building Engineering Services from the Nottingham Trent University in the UK.
Hereva Consultants are retained by many of the local biopharma firms, from start-up ventures to internationally recognized firms, to provide project planning, management and a wide range of consulting services. They have offices in Boston, San Diego and London.
Javier Arguedas | North America Partner Development Executive, Waldner
Javier Arguedas, right after graduating from Wittenberg Univ. (OH), started his professional career within the Project Business. He was hired by a Spanish Consortium of 5 companies to coordinate and design Pharmaceutical Production Premises, specializing in Cleanrooms for Solid Forms. In 1998, the firm Waldner wanted to start its business in Spain, proposing to Javier the possibility of becoming the official dealer. This challenge was accepted, and ever since Waldner has been well known and recognized in the Spanish Market. After 7 years designing and installing labs, not only in Spain but also in Latin-American, Javier decided to change to the lab equipment business, along again with cleanroom.
In 2008, Javier decided to come back to Waldner and take care of the whole Sales Organization. Now, with his broad Lab-planning knowledge with more than 20 years in this field, Javier was able to place Waldner Spain in the leading market position, confirming that the lab-planning approach, offering solutions to the end users and Engineers was the right way to come up with state-of-the-art installations. In January 2016 Waldner appointed Javier to head the US & Canadian Markets as both markets are very oriented to the Lab-planning approach, and therefore, his skills and experience, along with the large product portfolio of the SCALA System, will impact the lab designing for both markets soon.
Cancellation Policy: If you can no longer attend an event, we encourage you to find a substitution; sub-stitutions are welcome at any time. Full refunds will be granted if cancellation is made within 72 hours of the start time. No refunds will be made for no-shows. Email firstname.lastname@example.org for substitu-tion or refund requests.
We use PayPal as our payment processor. However, you will have the option to use a credit card or debit card for payment. You do not have to have a PayPal account to register and pay for an event. When checking out you will have to choose PayPal as the payment method. However, on the next screen you’ll see the option to pay with a debit card or credit card.